Biotech & Medtech
Biotech & Medtech news — Wednesday 14 October 2026
20 stories from 3 sources, every one in English. Each links to its publisher.
-
Former FDA officials blast DOGE as ‘one of the biggest disasters in American history’
STAT News
BOSTON — Three former Food and Drug Administration chiefs lit into the Trump administration Wednesday, criticizing the now former FDA officials who oversaw a massive staffing exodus and saying they robbed the agency of institutional…
-
As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university
STAT News
BOSTON — This fall, the Massachusetts Institute of Technology, where 95% of students are STEM majors, enrolled nearly 500 fewer graduate students — a 20% drop compared to 2024. The reduction is a direct result of a $100 million cut in…
-
HealthTap Introduces Virtual Primary Care Program for DME Suppliers
MedCity News
HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy. The post HealthTap Introduces Virtual Primary Care Program for DME Suppliers appeared first on MedCity News .
-
Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building
MedCity News
Ultragenyx Pharmaceutical sold two priority review vouchers, each from an FDA approval of a gene therapy. Both therapies came from business deals and proceeds from the voucher sales put Ultragenyx in a better financial position to pursue…
-
STAT+: Trump administration delays new rule that could restrict imported medicines from Canada and overseas
STAT News
The Trump administration is delaying by 90 days a federal rule that could prevent Americans from obtaining prescription drugs from licensed international pharmacies. The move follows growing criticism that the rule, which was initially…
-
How consumer tech company Whoop is building for Medicare patients
STAT News
Whoop has never been known for marketing to an older population. Performance athletes headline ads for the wearable company, which aims to turn continuous streams of physiological data into useful insights for behavior change — mostly, for…
-
Healthleap Raises $38M to Expand AI Screening for Overlooked Conditions in Hospitalized Patients
MedCity News
Healthleap, a clinical AI platform that works within the EHR to screen hospitalized patients for conditions that might otherwise go undiagnosed, is supporting hospitals in finding at-risk patients sooner. The post Healthleap Raises $38M to…
-
Experimental Arrowhead RNAi drug hints at Alzheimer’s benefit
BioPharma Dive
In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.
-
Verastem cancer drug shows early promise in small study
BioPharma Dive
Wall Street analysts believe Verastem’s drug to now be “competitive” in what’s quickly become one of the most active and crowded areas of oncology research.
-
CVS to pay $315M to settle opioid prescribing allegations
BioPharma Dive
Prosecutors say the company filled unnecessary prescriptions that fueled the opioid epidemic. A spokesperson for CVS said the company admitted to no wrongdoing and “strongly disagreed” with the case’s claims.
-
STAT+: FDA adcomm members’ ties to industry under scrutiny
STAT News
Good morning. Yesterday, we got the devastating news that STAT’s infectious disease correspondent, Helen Branswell, passed away. She was a reporter I always looked up to and was also an incredibly generous colleague. Please take the time…
-
J＆J earnings set ‘negative tone’; Shkreli vs. the FTC
BioPharma Dive
A 6% sell-off in J&J shares was viewed by one analyst as emblematic of broader market volatility. Elsewhere, Gilead is collaborating with Vir and a biotech’s bid for a product expansion fell short.
-
Why Agentic AI Works in Hospitals When You Strip It Down
MedCity News
Many hospitals are now trying to use AI to automate processes and free up staff time, running simultaneous pilots to perform as many tasks as possible. This quickly leads to pilot sprawl — a state where organizations can no longer even say…
-
STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more
STAT News
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While…
-
STAT+: The startup chasing ‘general biological intelligence’
STAT News
This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Today is the first day of the STAT Summit in Boston! If…
-
STAT+: Sanofi avoids fine as EU accepts offer to end antitrust probe over disparaging rival vaccine
STAT News
European Union antitrust regulators accepted concessions from Sanofi to settle an investigation into an allegedly “misleading” campaign that disparaged the only rival flu vaccine recommended for vulnerable patients at risk for developing…
-
New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability
STAT News
We got devastating news yesterday. The inimitable Helen Branswell has died at age 69 . We’ll miss her so much. A huge loss for science, journalism, and STAT Helen Branswell — STAT’s renowned infectious diseases reporter, our best baker…
-
Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
STAT News
Picture a baby sleeping in a crib. Every second, her brain is forming more than a million new neural connections. The scaffolding for language, memory, attention, and thought is going up in real time, wire by wire. We don’t yet know who…
-
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
STAT News
Influential lobbying groups for doctors and hospitals, a health insurer, technology companies, and representatives from state governments met behind closed doors in Washington, D.C., in early October to develop guidelines for how to…
-
Opinion: How states can resist the potential Trump vaccine shortages
STAT News
Vaccine skepticism has worked its way from the fringes of the public to the highest levels of the federal government. The Trump administration is reportedly considering changes to a critical policy, the Vaccine Injury Compensation Program…